[Elsevier] Vitiligo Biomarker CXCL10 Correlates With Clinical Response to Ruxolitinib Cream in the Phase 2 Randomized TRuE-V Mechanism-of-Action Study |
|
This post will be closed automatically in 2026-10-22 19:18
Reward10points
|
| |
post
reply
points
30
10
THE DISSEMINATION OF TUMORS OF THE HEAD AND NECK VIA THE CRANIAL NERVES
10
Tourism demand forecasting using compound pattern recognition
20
Characterization of the grain boundary fundamental zone and Bayesian modeling of grain boundary energy
10
Fatal maternal outcome in two SARS-CoV-2 delta variant cases requiring cesarean section: a tertiary center experience
10
Insight into rapid vegetation dynamics in China＊s saltmarshes reveals overlooked coastal soil carbon storage
